6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: March 25, 2025
Period of Report: March 25, 2025
Accession Number: 0001013762-25-002205

View Document ↗ View on SEC.gov ↗